Population kinetics of gentamicin in neonates. 1993

W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Germany.

A population kinetic analysis was carried out on sparse plasma gentamicin (GE) concentration data from 469 neonates obtained as part of a routine therapeutic drug monitoring (TDM) programme in the hospital neonatology unit. The best predictors of the kinetic parameters of the monoexponential model, volume of distribution (Vd) and clearance (CL), were the weight (WT) and gestational age (GA). Vd of the neonates was only related to WT, whereas the half-life was only related to the GA. The clinical implications of the findings are that the initial dose per WT administered to premature infants should be larger than that for term infants, because of a larger Vd per unit WT, and the intervals between maintenance doses should extended due to the prolonged half-life. Apart from these general guidelines, specific dose recommendations are also given.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016231 Fluorescence Polarization Immunoassay Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations. Immunoassay, Fluorescence Polarization,Polarization Fluoroimmunoassay,Fluorescence Polarization Immunoassays,Fluoroimmunoassay, Polarization,Fluoroimmunoassays, Polarization,Immunoassays, Fluorescence Polarization,Polarization Fluoroimmunoassays,Polarization Immunoassay, Fluorescence,Polarization Immunoassays, Fluorescence

Related Publications

W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
January 1988, Developmental pharmacology and therapeutics,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
June 2001, Therapeutic drug monitoring,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
June 2007, Pharmacy world & science : PWS,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
January 1988, Therapeutic drug monitoring,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
January 1992, Pharmacotherapy,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
April 1995, The Annals of pharmacotherapy,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
November 2018, Pharmacotherapy,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
October 1999, Therapeutic drug monitoring,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
November 2014, British journal of clinical pharmacology,
W Weber, and G Kewitz, and K L Rost, and M Looby, and M Nitz, and L Harnisch
September 2000, The Pediatric infectious disease journal,
Copied contents to your clipboard!